Lupin’s arm recalling 2,724 bottles of Clomipramine hydrochloride Capsules

23 Apr 2025 Evaluate

Lupin’s arm -- Lupin Pharmaceuticals Inc. is recalling 2,724 bottles of Clomipramine hydrochloride Capsules USP, 25 mg in the US due to Failed Impurities/Degradation Specifications. This is an antidepressant medication which used in the treatment of obsessive-compulsive disorder. The company initiated the Class II recall on April 18, 2025.  

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×